NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of supplying crucial chemical intermediates that drive innovation in the pharmaceutical sector. Methyl 4-(Bromomethyl)-3-Methoxybenzoate, identified by its CAS number 70264-94-7, is a prime example of such a vital compound. Its significance is deeply rooted in its application as a key intermediate for Zafirlukast, a prominent medication used to combat asthma. This article examines the essential characteristics of this chemical and its pivotal role in the synthesis of this important therapeutic agent.

The compound presents itself as a white to off-white crystalline powder, indicating a high degree of purity, which is a non-negotiable requirement in pharmaceutical manufacturing. With a molecular formula of C10H11BrO3 and a molecular weight of 259.096, Methyl 4-(Bromomethyl)-3-Methoxybenzoate offers predictable chemical behavior. Its assay, typically ≥98.0%, confirms its suitability for precise Zafirlukast intermediate synthesis. These refined properties are what make it an indispensable component in the complex organic synthesis involved in producing advanced pharmaceuticals.

The primary application that defines the value of Methyl 4-(Bromomethyl)-3-Methoxybenzoate is its role in the creation of Zafirlukast. Zafirlukast is a selective leukotriene receptor antagonist, a class of drugs that effectively manages the symptoms of chronic asthma. Asthma is often exacerbated by leukotrienes, substances that cause inflammation and constriction of the airways. By blocking these leukotrienes, Zafirlukast helps to restore normal breathing and reduce the frequency and severity of asthma attacks. The structural features of Methyl 4-(Bromomethyl)-3-Methoxybenzoate, especially the bromomethyl moiety, are critical for constructing the Zafirlukast molecule, positioning it as a key asthma medication intermediate.

As a reliable supplier of pharmaceutical intermediate chemical, NINGBO INNO PHARMCHEM CO.,LTD. understands the critical nature of consistency and purity in our products. The demand for high purity methyl 4-(bromomethyl)-3-methoxybenzoate is directly linked to the efficacy of the final Zafirlukast product. Our commitment to stringent quality control ensures that manufacturers can depend on our supply chain for their Zafirlukast intermediate synthesis needs. This reliability is fundamental to the continuous production of essential respiratory medications.

Furthermore, Methyl 4-(Bromomethyl)-3-Methoxybenzoate is a valuable asset in the broader field of fine chemicals and research. Its well-defined chemical properties make it a versatile tool for chemists engaged in developing new synthetic methodologies or exploring novel drug candidates. Access to high-quality fine chemical CAS 70264-94-7 empowers researchers and manufacturers alike. The compound serves as a testament to the sophisticated processes employed in modern chemical manufacturing, ensuring that critical components for healthcare are readily available.

NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supporting the global pharmaceutical industry by providing high-caliber intermediates. Our expertise in chemical synthesis and our commitment to customer satisfaction make us a preferred partner for companies seeking reliable sourcing for their pharmaceutical needs. If you require information on Zafirlukast intermediate synthesis or seek a dependable supplier for your chemical requirements, please reach out to us. We are equipped to provide comprehensive solutions and quotations tailored to your specific needs.